CARsgen® U.S. Clinical Holds Lifted by FDA

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 154 155 156 157 158 159 160 Next Tail

10 Items Per Page (Page 157 / 521) Total 5204 Items

©copyright2009-2020 British Weekly      Contact Us   SiteMap